Works matching AU Dirven, L.

Results: 41

Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study.

Published in:

Journal of Neuro-Oncology, 2019, v. 142, n. 3, p. 463, doi. 10.1007/s11060-019-03117-y

By:

Kerkhof, M.;
Koekkoek, J. A. F.;
Vos, M. J.;
van den Bent, M. J.;
Taal, W.;
Postma, T. J.;
Bromberg, J. E. C.;
Kouwenhoven, M. C. M.;
Dirven, L.;
Reijneveld, J. C.;
Taphoorn, M. J. B.

Publication type:

Article

Clinical applicability of and changes in perfusion MR imaging in brain metastases after stereotactic radiotherapy.

Published in:

Journal of Neuro-Oncology, 2018, v. 138, n. 1, p. 133, doi. 10.1007/s11060-018-2779-7

By:

Kerkhof, M.;
Ganeff, I.;
Wiggenraad, R. G. J.;
Lycklama à Nijeholt, G. J.;
Hammer, S.;
Taphoorn, M. J. B.;
Dirven, L.;
Vos, M. J.

Publication type:

Article

Development of a questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumors: a pilot study.

Published in:

Journal of Neuro-Oncology, 2017, v. 132, n. 1, p. 145, doi. 10.1007/s11060-016-2352-1

By:

Oort, Q.;
Dirven, L.;
Meijer, W.;
Sikkes, S.;
Uitdehaag, B.;
Reijneveld, J.;
Taphoorn, M.

Publication type:

Article

Symptoms and medication management in the end of life phase of high-grade glioma patients.

Published in:

Journal of Neuro-Oncology, 2014, v. 120, n. 3, p. 589, doi. 10.1007/s11060-014-1591-2

By:

Koekkoek, J.;
Dirven, L.;
Sizoo, E.;
Pasman, H.;
Heimans, J.;
Postma, T.;
Deliens, L.;
Grant, R.;
McNamara, S.;
Stockhammer, G.;
Medicus, E.;
Taphoorn, M.;
Reijneveld, J.

Publication type:

Article

End of life care in high-grade glioma patients in three European countries: a comparative study.

Published in:

Journal of Neuro-Oncology, 2014, v. 120, n. 2, p. 303, doi. 10.1007/s11060-014-1548-5

By:

Koekkoek, J.;
Dirven, L.;
Reijneveld, J.;
Sizoo, E.;
Pasman, H.;
Postma, T.;
Deliens, L.;
Grant, R.;
McNamara, S.;
Grisold, W.;
Medicus, E.;
Stockhammer, G.;
Oberndorfer, S.;
Flechl, B.;
Marosi, C.;
Taphoorn, M.;
Heimans, J.

Publication type:

Article

Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy.

Published in:

Clinical Rheumatology, 2013, v. 32, n. 5, p. 585, doi. 10.1007/s10067-012-2136-8

By:

Dirven, L.;
Klarenbeek, N.;
Broek, M.;
Groenendael, J.;
Sonnaville, P.;
Kerstens, P.;
Huizinga, T.;
Dijkmans, B.;
Lems, W.;
Allaart, C.

Publication type:

Article

Risk factors for reported influenza and influenza-like symptoms in patients with rheumatoid arthritis.

Published in:

Scandinavian Journal of Rheumatology, 2012, v. 41, n. 5, p. 359, doi. 10.3109/03009742.2012.670729

By:

Dirven, L;
Huizinga, TWJ;
Allaart, CF

Publication type:

Article

Towards personalized treatment: predictors of short-term HAQ response in recent-onset active rheumatoid arthritis are different from predictors of rapid radiological progression.

Published in:

Scandinavian Journal of Rheumatology, 2012, v. 41, n. 1, p. 15, doi. 10.3109/03009742.2011.594964

By:

Dirven, L;
Visser, K;
Klarenbeek, NB;
Ewals, JAPM;
Han, KH;
Peeters, AJ;
Kerstens, PJSM;
Huizinga, TWJ;
Dijkmans, BAC;
Allaart, CF

Publication type:

Article

Antiseizure medication in patients with meningioma: a retrospective cohort study on the long-term impact on depression, anxiety and neurocognitive functioning.

Published in:

Journal of Neuro-Oncology, 2025, v. 174, n. 1, p. 227, doi. 10.1007/s11060-025-05025-w

By:

Laribi, L.;
Scheepens, J. C. C.;
Zamanipoor Najafabadi, A. H.;
Vos, M. J.;
van Furth, W. R.;
Peerdeman, S. M.;
Taphoorn, M. J. B.;
Van der Meer, P. B.;
Koekkoek, J. A. F.;
Biermasz, N. R.;
Boele, F. W.;
Dirven, L.;
Klein, M.;
Moojen, W. A.;
Reijneveld, J. C.;
Verstegen, M. J. T.

Publication type:

Article

P14.49 Prescription preferences of antiepileptic drugs in brain tumor patients: an international survey.

Published in:

Neuro-Oncology, 2021, v. 23, p. ii47, doi. 10.1093/neuonc/noab180.162

By:

Meer, P B van der;
Dirven, L;
Bent, M J van den;
Preusser, M;
Taphoorn, M J B;
Ruda, R;
Koekkoek, J A F

Publication type:

Article

P14.01 Incidence and impact of venous thromboembolism and major bleeding in patients with glioblastoma.

Published in:

Neuro-Oncology, 2021, v. 23, p. ii38, doi. 10.1093/neuonc/noab180.130

By:

Kaptein, F H J;
Stals, M A M;
Klaase, E;
Kapteijn, M Y;
Cannegieter, S C;
Taphoorn, M J B;
Dirven, L;
Huisman, M V;
Koekkoek, J A F;
Klok, F A

Publication type:

Article

P12.01 The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide.

Published in:

Neuro-Oncology, 2021, v. 23, p. ii30, doi. 10.1093/neuonc/noab180.103

By:

Opijnen, M P van;
Meer, P B van der;
Dirven, L;
Fiocco, M;
Kouwenhoven, M C M;
Bent, M J van den;
Taphoorn, M J B;
Koekkoek, J A F

Publication type:

Article

P09.04 T<sub>2</sub> hyperintense regions on MRI in gliomas: a comparison between routine clinical MRI and 7T MRI.

Published in:

Neuro-Oncology, 2021, v. 23, p. ii27, doi. 10.1093/neuonc/noab180.092

By:

Schmitz-Abecassis, B;
Osch, M J P van;
Dirven, L;
Taphoorn, M J B;
Koekkoek, J A F;
Bresser, J de

Publication type:

Article

P04.10 CDKN2A mutational status is associated with venous thromboembolism in patients with glioblastoma.

Published in:

Neuro-Oncology, 2021, v. 23, p. ii20, doi. 10.1093/neuonc/noab180.067

By:

Kapteijn, M Y;
Kaptein, F H J;
Stals, M A M;
Duinen, S G van;
Taphoorn, M J B;
Dirven, L;
Koekoek, J A F;
Klok, F A;
Versteeg, H H;
Buijs, J T

Publication type:

Article

OS10.8.A The effectiveness of antiepileptic drug duotherapies in glioma patients: a multicenter observational cohort study.

Published in:

Neuro-Oncology, 2021, v. 23, p. ii14, doi. 10.1093/neuonc/noab180.046

By:

Meer, P B van der;
Dirven, L;
Fiocco, M;
Vos, M;
Kouwenhoven, M C M;
Bent, M J van den;
Taphoorn, M J B;
Koekkoek, J A F

Publication type:

Article

OS05.4.A Do neurocognitive deficits explain the differences between brain tumour patients and their proxies assessing the patient's I-ADL?

Published in:

Neuro-Oncology, 2021, v. 23, p. ii7, doi. 10.1093/neuonc/noab180.021

By:

Oort, Q;
Dirven, L;
Sikkes, S;
Aaronson, N;
Boele, F;
Brannan, C;
Egeter, J;
Grant, R;
Klein, M;
Lips, I;
Narita, Y;
Sato, H;
Sztankay, M;
Stockhammer, G;
Talacchi, A;
Uitdehaag, B;
Reijneveld, J;
Taphoorn, M

Publication type:

Article

PL03.4.A Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period.

Published in:

Neuro-Oncology, 2021, v. 23, p. ii2, doi. 10.1093/neuonc/noab180.006

By:

Coomans, M;
Dirven, L;
Aaronson, N;
Baumert, B;
Bent, M van den;
Bottomley, A;
Brandes, A;
Chinot, O;
Coens, C;
Gorlia, T;
Herrlinger, U;
Keime-Guibert, F;
Malmström, A;
Martinelli, F;
Stupp, R;
Talacchi, A;
Wick, W;
Reijneveld, J;
Taphoorn, M

Publication type:

Article

Development and psychometric evaluation of item banks for memory and attention – supplements to the EORTC CAT Core instrument.

Published in:

Health & Quality of Life Outcomes, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12955-023-02199-7

By:

Rogge, AA;
Petersen, MA;
Aaronson, NK;
Conroy, T;
Dirven, L;
Fischer, F;
Habets, EJJ;
Reijneveld, JC;
Rose, M;
Sleurs, C;
Taphoorn, M;
Tomaszewski, KA;
Vachon, H;
Young, T;
Groenvold, M

Publication type:

Article

Interobserver variability in the radiological assessment of magnetic resonance imaging (MRI) including perfusion MRI in glioblastoma multiforme.

Published in:

European Journal of Neurology, 2016, v. 23, n. 10, p. 1528, doi. 10.1111/ene.13070

By:

Kerkhof, M.;
Hagenbeek, R. E.;
Kallen, B. F. W.;
Lycklama à Nijeholt, G. J.;
Dirven, L.;
Taphoorn, M. J. B.;
Vos, M. J.

Publication type:

Article

OS10.1 Survival analysis of IDH wildtype astrocytomas with molecular features of glioblastoma, WHO grade IV.

Published in:

Neuro-Oncology, 2019, v. 21, p. iii20, doi. 10.1093/neuonc/noz126.067

By:

Tesileanu, C M S;
Koekkoek, J A F;
Dirven, L;
Dubbink, H J;
Kros, J M;
Duinen, S G van;
Smits, M;
French, P J;
Taphoorn, M J B;
Bent, M J van den

Publication type:

Article

OS7.2 Measuring change in health-related quality of life: the added value of analysis on the individual patient level in glioma patients in clinical decision making.

Published in:

Neuro-Oncology, 2019, v. 21, p. iii14, doi. 10.1093/neuonc/noz126.045

By:

Coomans, M;
Taphoorn, M J B;
Aaronson, N;
Baumert, B G;
Bent, M van den;
Bottomley, A;
Brandes, A A;
Chinot, O;
Coens, C;
Gorlia, T;
Herrlinger, U;
Keime-Guibert, F;
Malmström, A;
Martinelli, F;
Stupp, R;
Talacchi, A;
Weller, M;
Wick, W;
Reijneveld, J C;
Dirven, L

Publication type:

Article

OS7.1 Impact of the addition of Rituximab to standard therapy with high dose methotrexate on health-related quality of life in primary central nervous system lymphoma patients.

Published in:

Neuro-Oncology, 2019, v. 21, p. iii13, doi. 10.1093/neuonc/noz126.044

By:

Meulen, M van der;
Dirven, L;
Bakunina, K;
Taphoorn, M J B;
Bent, M J van den;
Issa, S;
Doorduijn, J K;
Bromberg, J E C

Publication type:

Article

OS7.4 Calculating the net clinical benefit in brain tumor clinical trials by combining survival and health-related quality of life data using two methods: quality adjusted survival effect sizes (QASES) and joint modelling (JM).

Published in:

Neuro-Oncology, 2019, v. 21, p. iii14, doi. 10.1093/neuonc/noz126.047

By:

Coomans, M;
Dirven, L;
Bottomley, A;
Bent, M van den;
Sloan, J;
Stupp, R;
Weller, M;
Reijneveld, J C;
Taphoorn, M;
Aaronson, N;
Baumert, B G;
Brandes, A A;
Chinot, O;
Coens, C;
Gorlia, T;
Herrlinger, U;
Keime-Guibert, F;
Malmström, A;
Martinelli, F;
Talacchi, A

Publication type:

Article

OS3.6 Prediagnostic symptoms and signs of adult glioma: the patients' view.

Published in:

Neuro-Oncology, 2019, v. 21, p. iii9, doi. 10.1093/neuonc/noz126.030

By:

Peeters, M C M;
Dirven, L;
Koekkoek, J A F;
Gortmaker, E G;
Fritz, L;
Vos, M J;
Taphoorn, M J B

Publication type:

Article

OS3.5 Prescription medications in glioma patients and the prevalence of depression, anxiety and subjective cognitive impairment.

Published in:

Neuro-Oncology, 2019, v. 21, p. iii9, doi. 10.1093/neuonc/noz126.029

By:

Meer, P B van der;
Taphoorn, M J B;
Bent, M J van den;
Dirven, L;
Koekkoek, J

Publication type:

Article

OS3.3 Development of an EORTC questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumours: phase I-III.

Published in:

Neuro-Oncology, 2019, v. 21, p. iii9, doi. 10.1093/neuonc/noz126.027

By:

Oort, Q;
Dirven, L;
Boele, F;
Grant, R;
Sato, H;
Talacchi, A;
Young, T;
Reijneveld, J C;
Taphoorn, M J B

Publication type:

Article

OS3.1 Antiepileptic drugs and their association with depression, anxiety and subjective cognitive impairment in glioma patients.

Published in:

Neuro-Oncology, 2019, v. 21, p. iii8, doi. 10.1093/neuonc/noz126.025

By:

Meer, P B van der;
Taphoorn, M J B;
Bent, M J van den;
Dirven, L;
Koekkoek, J A F

Publication type:

Article

P05.78 Improving quality of care of meningioma patients: initial evaluation of issues in care trajectories according to the Plan-Do-Study-Act Cycle.

Published in:

Neuro-Oncology, 2018, v. 20, p. iii321, doi. 10.1093/neuonc/noy139.404

By:

Najafabadi, A H Zamanipoor;
Mortel, J P M van de;
Lobatto, D J;
Brandsma, D;
Peul, W C;
Taphoorn, M J B;
Dirven, L;
Furth, W R van

Publication type:

Article

P05.65 The caregiver burden in meningioma: long-term results and its effects on caregiver's health-related quality of life, anxiety and depression.

Published in:

Neuro-Oncology, 2018, v. 20, p. iii318, doi. 10.1093/neuonc/noy139.391

By:

Najafabadi, A H Zamanipoor;
Meer, P B van der;
Boele, F W;
Reijneveld, J C;
Taphoorn, M J B;
Klein, M;
Furth, W R van;
Dirven, L;
Peerdeman, S M;
Group, The Netherlands Meningioma Research

Publication type:

Article

P05.64 The disease burden of meningioma patients: long-term results on work productivity and healthcare consumption.

Published in:

Neuro-Oncology, 2018, v. 20, p. iii318, doi. 10.1093/neuonc/noy139.390

By:

Najafabadi, A H Zamanipoor;
Meer, P B van der;
Boele, F W;
Reijneveld, J C;
Taphoorn, M J B;
Furth, W R van;
Dirven, L;
Peerdeman, S M;
Group, The Netherlands Meningioma Research

Publication type:

Article

P01.093 The level of reporting of neurocognitive outcomes in randomized controlled trials of brain tumour patients: a systematic review.

Published in:

Neuro-Oncology, 2018, v. 20, p. iii252, doi. 10.1093/neuonc/noy139.135

By:

Habets, E J J;
Taphoorn, M J B;
Klein, M;
Vissers, T;
Dirven, L

Publication type:

Article

P01.079 Determining the content validity of measures of basic and instrumental activities of daily living (ADL) in patients with brain tumours, a systematic review.

Published in:

Neuro-Oncology, 2018, v. 20, p. iii248, doi. 10.1093/neuonc/noy139.121

By:

Oort, Q;
Taphoorn, M;
Sikkes, S;
Uitdehaag, B;
Reijneveld, J;
Dirven, L

Publication type:

Article

P01.049 Prediagnostic presentations of glioma in primary care: a case-control study.

Published in:

Neuro-Oncology, 2018, v. 20, p. iii240, doi. 10.1093/neuonc/noy139.091

By:

Peeters, M C M;
Dirven, L;
Waal, M W M de;
Numans, M E;
Taphoorn, M J B

Publication type:

Article

P01.042 Symptom clusters in newly diagnosed glioma patients: which clusters are associated with functioning and global health status?.

Published in:

Neuro-Oncology, 2018, v. 20, p. iii238, doi. 10.1093/neuonc/noy139.084

By:

Coomans, M B;
Dirven, L;
Bent, M van den;
Bottomley, A;
Coens, C;
Stupp, R;
Weller, M;
Reijneveld, J C;
Taphoorn, M J B;
team, CODAGLIO project

Publication type:

Article

OS4.2 The long-term disease burden of meningioma patients: results on health-related quality of life, cognitive function, anxiety and depression.

Published in:

Neuro-Oncology, 2018, v. 20, p. iii222, doi. 10.1093/neuonc/noy139.027

By:

Najafabadi, A H Zamanipoor;
Meer, P B van der;
Boele, F W;
Reijneveld, J C;
Taphoorn, M J B;
Klein, M;
Furth, W R van;
Dirven, L;
Peerdeman, S M;
Group, The Netherlands Meningioma Research

Publication type:

Article

OS4.6 Does radiation target volume affect health-related quality of life in patients with low grade glioma on the short-term? - a secondary analysis of the EORTC 22033–26033 trial.

Published in:

Neuro-Oncology, 2018, v. 20, p. iii223, doi. 10.1093/neuonc/noy139.031

By:

Seidel, C;
Dirven, L;
Rejneveld, J C;
Coens, C;
Taphoorn, M J B;
Gorlia, T;
Tzuk-Shina, T;
Back, M;
Stupp, R;
Baumert, B

Publication type:

Article

O9.05 COGNITIVE FUNCTIONING, HEALTH-RELATED QUALITY OF LIFE AND SURVIVAL AFTER STEREOTACTIC RADIOTHERAPY IN PATIENTS WITH BRAIN METASTASES.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii21, doi. 10.1093/neuonc/nou174.76

By:

Habets, E.J.J.;
Dirven, L.;
Wiggenraad, R.;
Zwinkels, H.;
Lycklamaá Nijeholt, G.J.;
Taphoorn, M.J.B.

Publication type:

Article

O9.08 END OF LIFE CARE IN HIGH-GRADE GLIOMA PATIENTS IN THREE EUROPEAN COUNTRIES: A COMPARATIVE STUDY.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii22, doi. 10.1093/neuonc/nou174.79

By:

Koekkoek, J.A.F.;
Dirven, L.;
Reijneveld, J.C.;
Pasman, H.R.W.;
McNamara, S.;
Grisold, W.;
Stockhammer, G.;
Marosi, C.;
Taphoorn, M.J.B.;
Heimans, J.J.

Publication type:

Article

P15.04 DEVELOPMENT OF A NEW QUESTIONNAIRE TO MEASURE INSTRUMENTAL ACTIVITIES OF DAILY LIVING (I-ADL) IN PATIENTS WITH PRIMARY BRAIN TUMOURS: RESULTS OF PHASE 1.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii74, doi. 10.1093/neuonc/nou174.283

By:

Dirven, L.;
Meijer, W.;
Sikkes, S.A.M.;
Reijneveld, J.C.;
Aaronson, N.K.;
Uitdehaag, B.M.J.;
Taphoorn, M. J. B.

Publication type:

Article

Evaluating Adherence to a Treat-to-Target Protocol in Recent-Onset Rheumatoid Arthritis: Reasons for Compliance and Hesitation.

Published in:

2016

By:

Markusse, I. M.;
Dirven, L.;
Han, K. H.;
Ronday, H. K.;
de Sonnaville, P. B. J.;
Kerstens, P. J. S. M.;
Lems, W. F.;
Huizinga, T. W. J.;
Allaart, C. F.

Publication type:

journal article

Changes in hand bone mineral density and the association with the level of disease activity in patients with rheumatoid arthritis: Bone mineral density measurements in a multicenter randomized clinical trial.

Published in:

Arthritis Care & Research, 2011, v. 63, n. 12, p. 1691, doi. 10.1002/acr.20612

By:

Dirven, L.;
Güler-Yüksel, M.;
de Beus, W. M.;
Ronday, H. K.;
Speyer, I.;
Huizinga, T. W. J.;
Dijkmans, B. A. C.;
Allaart, C. F.;
Lems, W. F.

Publication type:

Article